Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 19 de 19
Filter
1.
Zhongguo Zhong Yao Za Zhi ; 45(6): 1219-1224, 2020 Mar.
Article in Chinese | MEDLINE | ID: mdl-32281328

ABSTRACT

With the rapid outbreak of COVID-19, traditional Chinese medicine(TCM) has been playing an active role against the epidemic. However, the screening of TCM is limited by the development cycle and laboratory conditions, which greatly limits the screening speed. This study established optimization docking models and virtual screening to discovery potential active herbs for the prevention and treatment of the novel coronavirus based on molecular docking technology. The crystal structures of 3 CL protease(Mpro) and papain-like protease(PLP) were obtained from PDB database and homologous modeling respectively, and were used to conduct virtual screening of TCMD 2009 database by CDOCKER program. The ingredients scored in the top 100 were selected respectively, and the candidate herbs were ranked by the numbers of hit molecules. Based on Mpro inhibitors screening, 12 322 potential active components were obtained, and the representative active components included aster pentapeptide A, ligustrazine, salvianolic acid B, etc., and Zingiberis Rhizoma Recens, Asteris Radix et Rhizoma, Notoginseng Radix et Rhizoma, Chuanxiong Rhizoma, Salviae Miltiorrhizae Radix et Rhizoma, Zingiberis Rhizoma, Dianthi Herba, Rhei Radix et Rhizoma, Cistanches Herba were obtained. While 11 294 potential active ingredients were obtained by PLP inhibitor screening, representative active ingredients included gingerketophenol, ginkgol alcohol, ferulic acid, etc., and Codonopsis Radix, Notopterygii Rhizoma et Radix, Zingiberis Rhizoma Recens, Ginkgo Semen, Chuanxiong Rhizoma, Trichosanthis Fructus, Paeoniae Radix Alba, Psoraleae Fructus, Sophorae Flavescentis Radix, Notoginseng Radix et Rhizoma, Angelicae Sinensis Radix were chosen. By combining the diagnosis and treatment scheme of Hunan province's and angiotensin converting enzyme 2(ACE2) inhibitors screening from literature, present study also discussed the rational application of candidate herbs to this epidemic situation. Trichosanthis Fructus obtained by PLP inhibitors screening and Fritillaria verticillata obtained by ACE2 inhibitors screening were parts of the Sangbei Zhisou Powder and Xiaoxianxiong Decoction, which might be applicable to the syndromes of cough and dyspnea. Rhei Radix et Rhizoma screened by Mpro and Trichosanthis Fructus screened by PLP were contained in Maxing Shigan Decoction and Xuanbai Chengqi Decoction, and could be applied to the syndromes of epidemic virus blocking lung. Mori Folium, Lonicerae Japonicae Flos and Forsythiae Fructus obtained by ACE2 inhibitors screening were included in the Sangju Decoction and Yinqiaosan, which might be applicable to the syndromes of warm pathogen attacking lung and cough and dyspnea. The results of this study are intended to provide a reference for the further development of traditional Chinese medicine to deal with the new epidemic.


Subject(s)
Angiotensin-Converting Enzyme Inhibitors/pharmacology , Betacoronavirus/drug effects , Coronavirus Infections/drug therapy , Drugs, Chinese Herbal/pharmacology , Medicine, Chinese Traditional , Pneumonia, Viral/drug therapy , Angiotensin-Converting Enzyme 2 , COVID-19 , Drug Evaluation, Preclinical , Humans , Molecular Docking Simulation , Pandemics , Peptidyl-Dipeptidase A , SARS-CoV-2 , COVID-19 Drug Treatment
2.
Zhongguo Zhong Yao Za Zhi ; 45(6): 1225-1231, 2020 Mar.
Article in Chinese | MEDLINE | ID: mdl-32281329

ABSTRACT

Since the outbreak of 2019-nCoV, the epidemic has developed rapidly and the situation is grim. LANCET figured out that the 2019-nCoV is closely related to "cytokine storm". "Cytokine storm" is an excessive immune response of the body to external stimuli such as viruses and bacteria. As the virus attacking the body, it stimulates the secretion of a large number of inflammatory factors: interleukin(IL), interferon(IFN), C-X-C motif chemokine(CXCL) and so on, which lead to cytokine cascade reaction. With the exudation of inflammatory factors, cytokines increase abnormally in tissues and organs, interfering with the immune system, causing excessive immune response of the body, resulting in diffuse damage of lung cells, pulmonary fibrosis, and multiple organ damage, even death. Arachidonic acid(AA) metabolic pathway is principally used to synthesize inflammatory cytokines, such as monocyte chemotactic protein 1(MCP-1), tumor necrosis factor(TNF), IL, IFN, etc., which is closely related to the occurrence, development and regression of inflammation. Therefore, the inhibition of AA metabolism pathway is benefit for inhibiting the release of inflammatory factors in the body and alleviating the "cytokine storm". Based on the pharmacophore models of the targets on AA metabolic pathway, the traditional Chinese medicine database 2009(TCMD 2009) was screened. The potential herbs were ranked by the number of hit molecules, which were scored by pharmacophore fit value. In the end, we obtained the potential active prescriptions on "cytokine storm" according to the potential herbs in the "National novel coronavirus pneumonia diagnosis and treatment plan(trial version sixth)". The results showed that the hit components with the inhibitory effect on AA were magnolignan Ⅰ, lonicerin and physcion-8-O-ß-D-glucopy-ranoside, which mostly extracted from Magnoliae Officinalis Cortex, Zingiberis Rhizoma Recens, Lonicerae Japonicae Flos, Rhei Radix et Rhizoma, Salviae Miltiorrhizae Radix et Rhizoma, Scutellariae Radix, Gardeniae Fructus, Ginseng Radix et Rhizoma, Arctii Fructus, Dryopteridis Crassirhizomatis Rhizoma, Paeoniaeradix Rubra, Dioscoreae Rhizoma. Finally the anti-2019-nCoV prescriptions were analyzed to obtain the potential active prescriptions on AA metabolic pathway, Huoxiang Zhengqi Capsules, Jinhua Qinggan Granules, Lianhua Qingwen Capsules, Qingfei Paidu Decoction, Xuebijing Injection, Reduning Injection and Tanreqing Injection were found that may prevent 2019-nCoV via regulate cytokines. This study intends to provide reference for clinical use of traditional Chinese medicine to resist new coronavirus.


Subject(s)
Arachidonic Acid/metabolism , Coronavirus Infections/drug therapy , Coronavirus Infections/immunology , Cytokines/immunology , Drugs, Chinese Herbal/pharmacology , Pneumonia, Viral/drug therapy , Pneumonia, Viral/immunology , Betacoronavirus , COVID-19 , Humans , Medicine, Chinese Traditional , Metabolic Networks and Pathways , Pandemics , SARS-CoV-2 , COVID-19 Drug Treatment
3.
Chin J Nat Med ; 17(8): 608-615, 2019 Aug.
Article in English | MEDLINE | ID: mdl-31472898

ABSTRACT

In an effort to understand the molecular events contributing to the cytotoxicity activity of resveratrol (RSV), we investigated its effects on human lung adenocarcinoma epithelial cell line A549 at different concentrations. Cellular nucleoside metabolic profiling was determined by an established liquid chromatography-mass spectrometry method in A549 cells. RSV resulted in significant decreases and imbalances of deoxyribonucleoside triphosphates (dNTPs) pools suppressing subsequent DNA synthesis. Meanwhile, RSV at high concentration caused significant cell cycle arrest at S phase, in which cells required the highest dNTPs supply than other phases for DNA replication. The inhibition of DNA synthesis thus blocked subsequent progression through S phase in A549 cells, which may partly contribute to the cytotoxicity effect of RSV. However, hydroxyurea (HU), an inhibitor of RNR activity, caused similar dNTPs perturbation but no S phase arrest, finally no cytotoxicity effect. Therefore, we believed that the dual effect of high concentration RSV, including S phase arrest and DNA synthesis inhibition, was required for its cytotoxicity effect on A549 cells. In summary, our results provided important clues to the molecular basis for the anticancer effect of RSV on epithelial cells.


Subject(s)
Adenocarcinoma of Lung/pathology , Cell Cycle/drug effects , Deoxyribonucleotides/metabolism , Epithelial Cells/drug effects , Lung Neoplasms/pathology , Resveratrol/pharmacology , A549 Cells , Adenocarcinoma of Lung/metabolism , Cell Survival/drug effects , Dose-Response Relationship, Drug , Humans , Hydroxyurea/pharmacology , Lung Neoplasms/metabolism , S Phase Cell Cycle Checkpoints/drug effects
4.
Chin Med ; 14: 22, 2019.
Article in English | MEDLINE | ID: mdl-31164916

ABSTRACT

BACKGROUND: Sanguisorba officinalis, a popular Chinese herb, called DiYu, has been shown to inhibit the growth of many human cancer cell lines, including colorectal cancer cells. The aims of this study were to discover the active compound and molecular mechanism of S. officinalis against Wnt/ß-catenin signaling pathway and develop Wnt inhibitors from natural products as anti-colorectal cancer agents. METHODS: 1,4,6-Tri-O-galloyl-ß-d-glucopyranose (TGG) was obtained by the preparative HPLC. The effect of DiYu on proliferation of NIH3T3 and HT29 was detected by MTT assay. Luciferase reporter assay was applied to investigate the activity of Wnt/ß-catenin signaling in NIH3T3. The expression levels of mRNA and protein were detected by RT-PCR and western blot. Immunofluorescence assay was used to measure the level of ß-catenin in cytoplasm and nucleus. Transcriptomic profiling study was performed to investigate the molecular mechanism of DiYu on the Wnt/ß-catenin signaling pathway. RESULTS: TGG significantly inhibited the Wnt/ß-catenin signaling pathway, down-regulated the expression of ß-catenin and Wnt target genes (Dkk1, c-Myc, FGF20, NKD1, Survivin), up-regulated the levels of cleaved caspase3, cleaved PARP and ratio of Bax/Bcl-2, which may explain the apoptosis of HT29. CONCLUSIONS: Our study enhanced the discovery of the materials and elucidation of mechanisms that account for the anti-Wnt activity of natural inhibitor (DiYu) and identified the potential of TGG to be developed as anti-colorectal cancer drugs.

5.
Saudi Pharm J ; 27(1): 25-32, 2019 Jan.
Article in English | MEDLINE | ID: mdl-30627049

ABSTRACT

Rhei rhizome (Rheum officinale Baill.) (RR) contains a large number of anthraquinone bioactive, yet little is known of the combined effect of these anthraquinones in a mixture. The goals of this study were: to determine the inhibitory potencies of individual anthraquinones and whole RR extract against human liver microsomal CYP1A2/3A4 activity, to predict the content of anthraquinones in RR using the concentration addition (CA) model, and to compare predicted and empirical contents in the same RR sample. Anthraquinone concentrations in the RR extract were determined using HPLC. The inhibitory potencies of individual anthraquinones were determined in incubations containing human liver microsomes. The study results were used to predict an effect-based dose measure of the anthraquinones in RR using the CA model. An empirical dose measure also was determined in the whole RR extract using the CYP1A2/3A4-based bioassay. For the CYP1A2-based studies, the predicted and empirical dose measures of anthraquinones were identical; they were 12.0 ±â€¯1.80 and 12.20 ±â€¯0.81 mg aloe-emodin equivalents/g RR, respectively. For the CYP3A4-based studies, the predicted and empirical dose measures were different; they were 2.80 ±â€¯0.10 and 19.04 ±â€¯0.41 mg aloe-emodin equivalents/g RR, respectively. Only the CYP1A2-based CA model which assumed additive effects of RR anthraquinones predicted an effect-based dose measure that was verifiable by empirical data. The CA model provides an alternative approach to the CYP1A2/3A4-based bioassay or empirical method to screen for the anthraquinones in RR. The CA model as described in this study is applicable to other botanical drugs, plant-based foods and dietary supplements.

6.
Anal Chem ; 91(1): 1019-1026, 2019 01 02.
Article in English | MEDLINE | ID: mdl-30525455

ABSTRACT

Investigation into intracellular ribonucleotides (RNs) and deoxyribonucleotides (dRNs) is important for studies of the mechanism of many biological processes, such as RNA and DNA synthesis and DNA repair, as well as metabolic and therapeutic efficacy of nucleoside analogues. However, current methods are still unsatisfactory for determination of nucleotides in complex matrixes. Here we describe a novel method for the determination of RN and dRN pools in cells based on fast derivatization with (trimethylsilyl)diazomethane (TMSD) followed by quantification using liquid chromatography-tandem mass spectrometry (LC-MS/MS). Derivatization was accomplished in 3 min, and each derivatized nucleotide not only had a sufficient retention on reversed-phase column by introduction of methyl groups but also exhibited a unique ion transition which consequently eliminated mutual interference in LC-MS/MS. Chromatographic separation was performed on a C18 column with a simple acetonitrile-water gradient elution system, which avoided contamination and ion suppression caused by ion-pairing reagents. The developed method was fully validated and applied to the analysis of RNs and dRNs in cell samples. Moreover, results demonstrated that the applicability of this method could be extended to nucleoside analogues and their metabolites and could facilitate many applications in future studies.


Subject(s)
Deoxyribonucleotides/analysis , Diazomethane/chemistry , Ribonucleotides/analysis , A549 Cells , Chromatography, Liquid , Diazomethane/analogs & derivatives , HCT116 Cells , Humans , Tandem Mass Spectrometry , Tumor Cells, Cultured
7.
RSC Adv ; 8(19): 10197-10206, 2018 Mar 13.
Article in English | MEDLINE | ID: mdl-35540488

ABSTRACT

Sanguisorba officinalis (the Chinese name is DiYu, DY) exerts significant anti-proliferative activities against colorectal cancer (CRC) cells. Since most of CRC result from the aberrant activation of the Wnt/ß-catenin signaling pathway, inhibitors of the Wnt pathway are considered as promising anti-CRC agents. This study aimed to investigate whether DY could be a potential herbal Wnt inhibitor, and the bioactive constituents and underlying molecular mechanisms for DY's inhibiting activities would be studied as well. Accordingly, the inhibitory activities of DY and its main components against the Wnt pathway were assessed using the single-luciferase reporter assay based on HEK293 cells. Additionally, the levels of key Wnt-related genes or proteins were measured to verify the inhibitory effects on the Wnt pathway of CRC cells. Finally, the underlying mechanisms accounting for the efficacy of candidate drugs were explored by the transcriptomic study. Results show that DY and its tannins (RZ), and saponins (ZG) significantly inhibited the Wnt pathway of HEK293 cells activated by wnt3a. However, their respective constituents were not effective as expected. Additionally, DY and RZ prominently down-regulated the levels of ß-catenin and Wnt-targeted genes including Axin2, c-Myc or CyclinD1 of three CRC cells. Transcriptomic profiling study suggests that the down-regulation of the mRNA levels of Wnt-related genes such as LPAR6 may be associated with the inhibitory effects of DY and RZ on the Wnt pathway of HT29 cells. Therefore, our studies first uncovered the blocking activity of DY on the Wnt pathway, providing evidence for the rationale of developing Wnt inhibitors from DY as anti-CRC agents.

8.
Oncotarget ; 8(60): 101707-101719, 2017 Nov 24.
Article in English | MEDLINE | ID: mdl-29254198

ABSTRACT

The absolute and relative pool sizes of deoxyribonucleotides (dRNs) are essential in DNA replication fidelity, DNA damage and repair. We found in this study that although DNA damage induced by methyl methanesulfonate (MMS) seemed similar in cancer (HepG2) and normal (LO2) cells, more extensive alterations in ribonucleotides (RNs) and dRNs pools occurred in HepG2 cells indicating that HepG2 cells were more vigilant to DNA damage. After 10 h repair, RNs pools were still severely perturbed in LO2 cells. Compared to LO2 cells, deoxyribonucleotide triphosphates (dNTPs) pools in HepG2 cells elevated by more folds which could facilitate more efficient DNA repair and improve survival probability following DNA damage, although this should definitely lead to higher mutation rates. DNA repair was more efficient in HepG2 cells at S phase and it partly came to an end while DNA repair was still uncompleted in LO2 cells outside S phase. In conclusion, our results demonstrated that HepG2 and LO2 cells presented many differences in nucleotide metabolism, cell cycle checkpoints and DNA repair pathways in response to DNA damage, which could be potential targets for cancer treatment.

9.
Molecules ; 22(3)2017 Mar 21.
Article in English | MEDLINE | ID: mdl-28335578

ABSTRACT

Despite the apparent clinical benefits of high-dose cytarabine (Ara-C) over lower dose Ara-C in acute myeloid leukemia (AML) therapy, the mechanism behind high-dose Ara-C therapy remains uncertain. In this study, a LC-MS-based method was carried out to investigate the metabolic alteration of ribonucleotide and deoxyribonucleotide in human promyelocytic leukemia cells (HL-60) after treatment with Ara-C to reveal its antitumor mechanism. The metabolic results revealed that four nucleotides (ATP, ADP, CDP, and dCTP) could be used as potential biomarkers indicating the benefit of high-dose Ara-C over lower dose Ara-C treatment. Combining metabolic perturbation and cell cycle analysis, we conjectured that, apart from the acknowledged mechanism of Ara-C on tumor inhibition, high-dose Ara-C could present a specific action pathway. It was suggested that the pronounced rise in AMP/ATP ratio induced by high-dose Ara-C can trigger AMP-activated protein kinase (AMPK) and subsequently Forkhead Box, class O (FoxO), to promote cell cycle arrest. Moreover, the significant decrease in CDP pool induced by high-dose Ara-C might further accelerate the reduction of dCTP, which then aggravates DNA synthesis disturbance. As a result, all of these alterations led to heightened tumor inhibition. This study provides new insight in the investigation of potential mechanisms in the clinical benefits of high-dose Ara-C in therapy for AML.


Subject(s)
Antimetabolites, Antineoplastic/pharmacology , Cytarabine/pharmacology , Deoxyribonucleotides/analysis , Ribonucleotides/analysis , AMP-Activated Protein Kinases/metabolism , Cell Cycle/drug effects , Gas Chromatography-Mass Spectrometry , Gene Expression Regulation, Neoplastic/drug effects , HL-60 Cells , Humans
10.
Sci Rep ; 6: 34245, 2016 Sep 27.
Article in English | MEDLINE | ID: mdl-27671231

ABSTRACT

Sanguisorba officinalis L. radix is a widely used herb called DiYu (DY) in China and has an extensive range of bioactivities, including anti-cancer, anti-inflammatory, and anti-oxidative activities. However, there is little evidence to support its anti-cancer effects against colorectal cancer (CRC). The first-line chemotherapeutic agent 5-fluorouracil (5-FU) is used to treat CRC, but its efficiency is hampered by acquired drug resistance. This study found that a water extract of DY exerted anti-proliferative effects against two CRC cell lines (HCT-116 and RKO), and it sensitized CRC cells to 5-FU therapy by activating a reactive oxygen species (ROS)-mediated, mitochondria-caspase-dependent apoptotic pathway. Co-treatment of DY and 5-FU significantly elevated ROS levels, up-regulated Bax/Bcl-2 ratio and triggered mitochondrial dysfunction, followed by a release of cytochrome c and up-regulation of proteins such as cleaved-caspase-9/3 and cleaved-PARP. Additionally, the induction of autophagy may be involved in mediating synergism of DY in HCT-116 cells. Gallic acid (GA), catechinic acid (CA) and ellagic acid (EA) were identified as the potential chief constituents responsible for the synergistic effects of DY. In conclusion, co-treatment of DY, specifically GA, CA and EA, with 5-FU may be a potential alternative therapeutic strategy for CRC by enhancing an intrinsic apoptotic pathway.

11.
J Anal Methods Chem ; 2013: 827361, 2013.
Article in English | MEDLINE | ID: mdl-23738236

ABSTRACT

A simple and efficient HPLC-DAD (225 nm) method was developed and validated for the simultaneous determination of limonin and six key alkaloids (evodiamine, rutaecarpine, 1-methyl-2-undecyl-4(1H)-quinolone, evocarpine, 1-methy-2-[(6Z,9Z)]-6,9-pentadecadienyl-4-(1H)-quinolone, and dihydroevocarpine) in Evodia rutaecarpa (Juss.) Benth, which has been widely used as one of the Traditional Chinese Medicines. The chromatographic separation was carried out on a Hypersil BDS C18 column, and gradient elution was employed with a mobile phase containing acetonitrile and water. Contents of the analytes in 18 batches of samples were analyzed by ultrasonic extraction with ethanol and water mixture (80 : 20, v/v) followed by HPLC analysis. Separation of the seven analytes was achieved within 60 min with good linearity (r > 0.999). The RSD of both the intraday and interday precision was below 1.85%. The accuracy at different concentrations was within the range of 97.91 to 100.49%. Hierarchical clustering analysis was performed to differentiate and classify the samples based on the contents of the seven constituents. This study indicated that the quality control of E. rutaecarpa could be simplified to the measurement of four constituents, and that limonin, 1-methyl-2-undecyl-4(1H)-quinolone, and dihydroevocarpine should also be served as the chemical markers together with evodiamine for the quality control of Evodia rutaecarpa (Juss.) Benth.

12.
J Ethnopharmacol ; 144(2): 300-4, 2012 Nov 21.
Article in English | MEDLINE | ID: mdl-23026308

ABSTRACT

ETHNOPHARMACOLOGICAL RELEVANCE: Radix astragali (RA) was the most frequently used traditional Chinese medicine (TCM) according to the statistics on 52 anti-diabetic formulas recorded in New National Traditional Chinese Medicine; it was employed in 34 out of the 52 formulas. The aim of this study was to elucidate potential pharmacokinetic interaction between RA and pioglitazone, and to provide guidance for clinical medicine safety. MATERIALS AND METHODS: A specific and rapid UPLC-MS/MS method was established to quantify pioglitazone in rat plasma. Then healthy and type 2 diabetes mellitus (T2DM) rats were each divided into control and RA decoction (RAD) administration groups-healthy, healthy-RAD, T2DM, T2DM-RAD; pharmacokinetics of pioglitazone was carried out after RAD was administrated to rats for 7 days. RESULTS: The established UPLC-MS/MS method was rapid, specific, and precise. Between healthy and healthy-RAD groups, half-life (T(1/2)), area under the curve (AUC (0-t)), Vz/F, and Cl/F showed mild yet statistically significant differences; no significant difference for any above parameter was detected between T2DM and T2DM-RAD groups. CONCLUSION: RAD co-administration did not affect the pharmacokinetics of pioglitazone especially in diabetic groups; RA and pioglitazone might be feasible herb-drug co-effectiveness.


Subject(s)
Drugs, Chinese Herbal/pharmacology , Herb-Drug Interactions , Hypoglycemic Agents/pharmacokinetics , Thiazolidinediones/pharmacokinetics , Animals , Astragalus Plant , Astragalus propinquus , Diabetes Mellitus, Experimental/metabolism , Diabetes Mellitus, Type 2/metabolism , Male , Pioglitazone , Rats , Rats, Wistar
13.
Bioanalysis ; 4(10): 1205-13, 2012 Jun.
Article in English | MEDLINE | ID: mdl-22651564

ABSTRACT

BACKGROUND: Dahuang Huanglian Xiexin Decoction (DHXD) is a classical formula in traditional Chinese medicines. In this study, a novel UPLC-MS/MS method was developed for the simultaneous quantification of rhein, emodin, berberine and baicalin, the major bioactive compounds of DHXD in rat plasma. RESULTS: The method possessed high sensitivity and ultrashort analysis time (7 min). Linearity, accuracy, precision and extraction recovery of four analytes were all satisfactory. The method was then successfully applied in a pharmacokinetic study of four bioactive components after a single oral administration of DHXD extract to rats. CONCLUSION: The method was applicable for simultaneous bioanalysis of rhein, emodin, berberine and baicalin.


Subject(s)
Anthraquinones/blood , Berberine/blood , Chromatography, High Pressure Liquid/methods , Emodin/blood , Flavonoids/blood , Tandem Mass Spectrometry/methods , Animals , Anthraquinones/pharmacokinetics , Berberine/pharmacokinetics , Colonic Diseases, Functional/drug therapy , Drugs, Chinese Herbal/pharmacokinetics , Emodin/pharmacokinetics , Flavonoids/pharmacokinetics , Medicine, Chinese Traditional , Plasma/chemistry , Rats , Reproducibility of Results , Sensitivity and Specificity , Statistics, Nonparametric
14.
Biomed Chromatogr ; 26(12): 1482-7, 2012 Dec.
Article in English | MEDLINE | ID: mdl-22334441

ABSTRACT

A novel, simple and rapid ultraperformance liquid chromatography/tandem mass spectrometry (UPLC-MS/MS) assay was established for quantification of saxagliptin in rat plasma. Plasma samples were processed by liquid-liquid extraction with ethyl acetate and chromatographed on a C18 column (2.1 × 50 mm i.d., 1.7 µm). The mobile phase consisted of methanol and 0.1% formic acid (40:60, v/v). Multiple reaction monitoring transitions were performed for detection in positive-ion mode with an electrospray ionization source. The calibration curve was linear over the concentration range of 0.5-100 ng/mL (R² > 0.99). All accuracy values were between 90.62 and 105.60% relative error and the intra- and inter-day precisions were less than 9.66% relative standard deviation. Extraction recovery was more than 81.01% and the matrix effect ranged from 90.27 to 109.15%. After validation, the method was applied to a pharmacokinetic study where healthy rats were orally given 0.5 mg/kg saxagliptin.


Subject(s)
Adamantane/analogs & derivatives , Chromatography, High Pressure Liquid/methods , Dipeptides/blood , Tandem Mass Spectrometry/methods , Acetates/chemistry , Adamantane/blood , Adamantane/chemistry , Adamantane/pharmacokinetics , Animals , Dipeptides/chemistry , Dipeptides/pharmacokinetics , Dipeptidyl-Peptidase IV Inhibitors/blood , Dipeptidyl-Peptidase IV Inhibitors/chemistry , Dipeptidyl-Peptidase IV Inhibitors/pharmacokinetics , Drug Stability , Least-Squares Analysis , Male , Rats , Rats, Wistar , Reproducibility of Results , Sensitivity and Specificity
15.
J Asian Nat Prod Res ; 13(4): 284-9, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21462030

ABSTRACT

Pueraria lobata flower is a medicinal herb for treating intoxication, hepatic, and gastrointestinal tract lesions induced by alcohol. This study aims to investigate the isoflavonoid glycosides in P. lobata flowers. Two new isoflavone compounds were isolated from the extract of P. lobata flowers. Their structures were determined to be 5,6,7,4'-tetrahydroxyisoflavone-6,7-di-O-ß-D-glucopyranoside and 5,6,7-trihydroxy-4'-methoxyisoflavone-6,7-di-O-ß-D-glucopyranoside on the basis of spectroscopic means including HR-ESI-MS, UV, IR, ¹H, and ¹³C NMR.


Subject(s)
Drugs, Chinese Herbal/chemistry , Glycosides/isolation & purification , Isoflavones/isolation & purification , Pueraria/chemistry , Flowers/chemistry , Glycosides/chemistry , Isoflavones/chemistry , Molecular Structure , Nuclear Magnetic Resonance, Biomolecular , Stereoisomerism
16.
Zhong Yao Cai ; 32(10): 1532-4, 2009 Oct.
Article in Chinese | MEDLINE | ID: mdl-20112712

ABSTRACT

OBJECTIVE: To study the chemical constituents of Flos Chrysanthemi Indici. METHODS: Chemical constituents were isolated and purified by silica gel and Sephadex LH-20 column chromatography. Their structures were indentified by means of physicochemical and spectral data. RESULTS: From the 80% ethanol extract of the material, seven compounds were isolated. Their structures were identified as luteolin (1), luteolin-7-O-beta-D-glucopyranoside (2), luteolin-7-O-(6"-O-acetyl)-beta-D-glucopyranoside (3), diosmetin (4), diosmetin-7-O-beta-D-glucopyranoside (5), eupatilin (6) and apigenin (7), respectively. CONCLUSION: Compounds 3-6 are isolated from Flos Chrysanthemi Indici for the first time.


Subject(s)
Chrysanthemum/chemistry , Flavones/isolation & purification , Flowers/chemistry , Plants, Medicinal/chemistry , Disaccharides/chemistry , Disaccharides/isolation & purification , Ethanol , Flavones/chemistry , Flavonoids/chemistry , Flavonoids/isolation & purification , Glucosides/chemistry , Glucosides/isolation & purification , Luteolin/chemistry , Luteolin/isolation & purification , Magnetic Resonance Spectroscopy
17.
Zhonghua Yan Ke Za Zhi ; 44(4): 349-53, 2008 Apr.
Article in Chinese | MEDLINE | ID: mdl-18844023

ABSTRACT

OBJECTIVE: To investigate the penetration of topical 1% voriconazole into the cornea and aqueous humor in New Zealand white rabbits. METHODS: It was a experimental study. Forty-eight healthy rabbits were randomly divided into groups A (21 cases), B (21 cases) and C (6 cases). Blank samples from group C were used to determine the essential parameters for the validation of analytical procedures. A single 50 microl drop of 1% voriconazole was administered in group A (non-debrided cornea) and group B (debrided cornea). The aqueous humor and the cornea were obtained at 2, 5, 10, 15, 30, 60 and 90 min after application. All samples were analyzed by high-performance liquid chromatography (HPLC). The HPLC system consisted of Waters 1525 pump, Phenomenex Luna C18 (250.0 mm x 4.6 mm, 5.0 microm) column, Phenomenex C18 (4.0 mm x 3.0 mm, 5.0 microm) analytical steel column and a Waters Empower data workstation. The UV detector was set to 255.0 nm. Methanol-0.04 mol/L ammonium hydroxide (62:38, V/V) was used as mobile phase and the flow rate was 0.8 ml/min. External standard was used in this assay. The pharmacokinetic parameters were calculated with nonlinear least square method by the computer. RESULTS: Calibration curves were linear over the range 0.1-15.0 mg/L. The concentration at 0.1 mg/L was the lowest quantified limit. The recovery of voriconazole from aqueous humor samples ranged from 91.06% to 94.80%, and ranged from 79.84% to 83.20% in the cornea samples. After single dose application, the drug concentration in aqueous humor peaked at 10 min in both group A [ (5.172 +/- 1.012) mg/L] and group B [(6.118 +/- 1.123) mg/L], and the parameters t(1/2 ke) in groups A and B were 6.859 min and 13.176 min, respectively. However, peak drug levels were achieved immediately at 2 min in the cornea [group A: (9.958 +/- 3.481) microg/g and group B: (158.476 +/- 10.462) microg/g]. The parameter t(1/2 beta) in nondebrided cornea was 94.938 min and 46.367 min in debrided corneas. CONCLUSIONS: Topical voriconazole exhibits excellent penetration into the cornea, and effective high drug levels are achieved in both the cornea and aqueous humor after single dose application. It can be a prominent agent for the treatment of fungal keratitis in the future.


Subject(s)
Ophthalmic Solutions/pharmacokinetics , Pyrimidines/pharmacokinetics , Triazoles/pharmacokinetics , Administration, Topical , Animals , Chromatography, High Pressure Liquid , Ophthalmic Solutions/administration & dosage , Pyrimidines/administration & dosage , Rabbits , Triazoles/administration & dosage , Voriconazole
18.
Yao Xue Xue Bao ; 43(3): 299-302, 2008 Mar.
Article in Chinese | MEDLINE | ID: mdl-18630268

ABSTRACT

A comprehensive HPLC-DAD-MS method was developed to study the chemical components of semi-bionic extract of Coptis-Evodia herb couple. The extract was isolated on a Hypersil BDS C18 column (4.6 mm x 200 mm, 5 microm) using acetonitrile-ammonium formic buffer as mobile phase by gradient elution. Detection was performed on DAD and MS equipped with an electrospray ionization (ESI) source by full scan and product full scan on positive mode. The chromatogram of Coptis-Evodia showed seventeen main peaks, eight of which were from Evodia while the others were from Coptis. By comparison of the retention time, the on-line UV spectra and MS spectra, four peaks were identified as jatrorrhizine, hydroxevodiamine, palmatine and berberine, and three peaks were deduced as epiberberine, columbamine and coptisine. In addition, berberine and palmatine were quantitatively determined. No new component was created in the semi-bionic extract of the herb couple, yet the solubilities of berberine and palmatine decreased.


Subject(s)
Coptis/chemistry , Evodia/chemistry , Berberine/analogs & derivatives , Berberine/chemistry , Berberine/isolation & purification , Berberine Alkaloids/chemistry , Berberine Alkaloids/isolation & purification , Chromatography, High Pressure Liquid/methods , Drugs, Chinese Herbal , Plant Extracts/chemistry , Spectrometry, Mass, Electrospray Ionization
19.
Zhongguo Zhong Yao Za Zhi ; 31(4): 316-9, 2006 Feb.
Article in Chinese | MEDLINE | ID: mdl-16706024

ABSTRACT

OBJECTIVE: To explore the effects of slenderstyle acanthopanax root-bark on cyclooxygenase in vivo and in vitro. METHOD: Contents of 6-keto-PGF1alpha in bovine aorta endothelial cells, PGE2 in mouse abdominal macrophages, and 6-keto-PGF1alpha in rat stomach tissue were determined. The ulcer index in rat gastric mucosa was measured. RESULT: COX-1 and COX-2 were inhibited by slenderstyle acanthopanax root-bark, and the inhibitive rate of COX-2 was higher than that of COX-1 at the same concentration. Necrotic injuries in health gastric mucosa were not produced, but the injuries previously induced by the ethanol worsened. CONCLUSION: One of the antirheumatic mechanisms of slender-root-bark might probably be mediating through inhibition of cyclooxygenase. style acanthopanax


Subject(s)
Cyclooxygenase 1/metabolism , Cyclooxygenase 2/metabolism , Drugs, Chinese Herbal/pharmacology , Eleutherococcus , Plants, Medicinal , 6-Ketoprostaglandin F1 alpha/metabolism , Animals , Aorta/enzymology , Cattle , Dinoprostone/metabolism , Drugs, Chinese Herbal/isolation & purification , Eleutherococcus/chemistry , Endothelial Cells/enzymology , Female , Gastric Mucosa/enzymology , Macrophages, Peritoneal/enzymology , Male , Mice , Plant Roots/chemistry , Plants, Medicinal/chemistry , Rats , Rats, Sprague-Dawley
SELECTION OF CITATIONS
SEARCH DETAIL
...